Abstract

BackgroundExtracorporeal membrane oxygenation (ECMO) research using large animals requires a significant amount of resources, slowing down the development of new means of ECMO anticoagulation. Therefore, this study developed and evaluated a new rat ECMO model using a 3D-printed mock-oxygenator.MethodsThe circuit consisted of tubing, a 3D-printed mock-oxygenator, and a roller pump. The mock-oxygenator was designed to simulate the geometry and blood flow patterns of the fiber bundle in full-scale oxygenators but with a low (2.5 mL) priming volume. Rats were placed on arteriovenous ECMO at a 1.9 mL/min flow rate at two different heparin doses (n = 3 each): low (15 IU/kg/h for eight hours) versus high (50 IU/kg/h for one hour followed by 25 IU/kg/h for seven hours). The experiment continued for eight hours or until the mock-oxygenator failed. The mock-oxygenator was considered to have failed when its blood flow resistance reached three times its baseline resistance.ResultsDuring ECMO, rats maintained near-normal mean arterial pressure and arterial blood gases with minimal hemodilution. The mock-oxygenator thrombus weight was significantly different (p < 0.05) between the low (0.02 ± 0.006 g) and high (0.003 ± 0.001 g) heparin delivery groups, and blood flow resistance was also larger in the low anticoagulation group.ConclusionsThis model is a simple, inexpensive system for investigating new anticoagulation agents for ECMO and provides low and high levels of anticoagulation that can serve as control groups for future studies.

Highlights

  • Extracorporeal membrane oxygenation (ECMO) research using large animals requires a significant amount of resources, slowing down the development of new means of ECMO anticoagulation

  • ECMO was successfully established in three rats from each group

  • During ECMO, the activated clotting time (ACT) for the HD group ranged from 152 to 220 s, which was similar to the clinical target range

Read more

Summary

Introduction

Extracorporeal membrane oxygenation (ECMO) research using large animals requires a significant amount of resources, slowing down the development of new means of ECMO anticoagulation. Numerous animal models have been developed to study thrombus formation in oxygenators. Most of these are large animal models, such as goats, sheep, pigs, or cows [6,7,8,9]. The advantages of a larger animal are simpler surgical procedures, the use of commercially available oxygenators, and a far lower risk of oversampling blood and risking hypotension or hemodilution. These experiments require large, experienced laboratory staff, greater use of disposable resources, and a full-scale operating environment. The rabbit model reduces the cost and complexity of study but remains expensive compared to rodent research [8, 10]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call